BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8980909)

  • 61. Suppression of urokinase expression and tumor metastasis by bikunin overexpression [mini-review].
    Kobayashi H
    Hum Cell; 2001 Sep; 14(3):233-6. PubMed ID: 11774742
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibitory effect of protease inhibitor on endothelial cell activation.
    Aosasa S; Ono S; Seki S; Takayama E; Tadakuma T; Hiraide H; Mochizuki H
    J Surg Res; 1998 Dec; 80(2):182-7. PubMed ID: 9878311
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endogenously produced urokinase amplifies tumor necrosis factor-alpha secretion by THP-1 mononuclear phagocytes.
    Sitrin RG; Shollenberger SB; Strieter RM; Gyetko MR
    J Leukoc Biol; 1996 Feb; 59(2):302-11. PubMed ID: 8604004
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Signal transduction pathways of membrane expression of proteinase 3 (PR-3) in human endothelial cells.
    Mayet WJ; Schwarting A; Orth T; Sibelius U; Hattar K; Meyer zum Büschenfelde KH
    Eur J Clin Invest; 1997 Nov; 27(11):893-9. PubMed ID: 9395784
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.
    Alfano M; Sidenius N; Panzeri B; Blasi F; Poli G
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8862-7. PubMed ID: 12084931
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of binding properties of urinary trypsin inhibitor to cell-associated binding sites on human chondrosarcoma cell line HCS-2/8.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Fujie M; Nishida T; Takigawa M; Terao T
    J Biol Chem; 2001 Apr; 276(17):13650-6. PubMed ID: 11278581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumor necrosis factor α stimulates expression and secretion of urokinase plasminogen activator in human dental pulp cells.
    Narita T; Muromachi K; Kamio N; Nakao S; Matsushima K; Hashizume H
    J Oral Sci; 2012; 54(4):329-36. PubMed ID: 23221158
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of chondroitin sulfate chains of urinary trypsin inhibitor in inhibition of LPS-induced increase of cytosolic free Ca2+ in HL60 cells and HUVEC cells.
    Kanayama N; Maehara K; Suzuki M; Fujise Y; Terao T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):560-4. PubMed ID: 9299551
    [TBL] [Abstract][Full Text] [Related]  

  • 69. cAMP inhibits cytokine-induced biosynthesis of tetrahydrobiopterin in human umbilical vein endothelial cells.
    Ohtsuki M; Shiraishi H; Kato T; Kuroda R; Tazawa M; Sumi-Ichinose C; Tada S; Udagawa Y; Itoh M; Hishida H; Ichinose H; Nagatsu T; Hagino Y; Nomura T
    Life Sci; 2002 Mar; 70(18):2187-98. PubMed ID: 12002810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modulatory effects of PKC activity on increased 92-kDa gelatinase secretion by neonatal alveolar macrophages.
    Delacourt C; Rouet-Benzineb P; Delclaux C; L'Hour J; Harf A; Lafuma C
    Am J Physiol; 1997 Nov; 273(5):L989-96. PubMed ID: 9374725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of the cellular binding site for the urinary trypsin inhibitor.
    Kobayashi H; Gotoh J; Fujie M; Terao T
    J Biol Chem; 1994 Aug; 269(32):20642-7. PubMed ID: 8051163
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of protein kinase inhibitors on IL-8/NAP-1 release from human umbilical vein endothelial cells.
    White JR; Lee JC
    Agents Actions; 1993; 39 Spec No():C73-6. PubMed ID: 8273591
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cells.
    Ohta S; Niiya K; Sakuragawa N; Fuse H
    Thromb Res; 2000 Mar; 97(5):343-7. PubMed ID: 10709910
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regulation of urokinase-type plasminogen activator production by cultured human cytotrophoblasts.
    Queenan JT; Kao LC; Arboleda CE; Ulloa-Aguirre A; Golos TG; Cines DB; Strauss JF
    J Biol Chem; 1987 Aug; 262(23):10903-6. PubMed ID: 3301845
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stimulation of cell-surface urokinase-type plasminogen activator activity and cell migration in vascular endothelial cells by a novel hexapeptide analogue of neurotensin.
    Ushiro S; Mizoguchi K; Yoshida S; Jimi S; Fujiwara T; Yoshida M; Wei ET; Kitabgi P; Amagaya S; Ono M; Kuwano M
    FEBS Lett; 1997 Dec; 418(3):341-5. PubMed ID: 9428741
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of radical scavengers on TNF alpha-mediated activation of the uPA in cultured cells.
    Egawa K; Yoshiwara M; Nose K
    Experientia; 1994 Oct; 50(10):958-62. PubMed ID: 7957773
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C.
    Phelps DT; Ferro TJ; Higgins PJ; Shankar R; Parker DM; Johnson A
    Am J Physiol; 1995 Oct; 269(4 Pt 1):L551-9. PubMed ID: 7485529
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8.
    Shinbo M; Niiya K; al-Mokdad M; Hayakawa Y; Hiraga K; Fujimaki M; Sakuragawa N
    Biochim Biophys Acta; 1995 Sep; 1268(3):293-9. PubMed ID: 7548228
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.
    Pepper MS; Vassalli JD; Montesano R; Orci L
    J Cell Biol; 1987 Dec; 105(6 Pt 1):2535-41. PubMed ID: 3121633
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tumor necrosis factor-alpha decreases pulmonary artery endothelial nitrovasodilator via protein kinase C.
    Johnson A; Phelps DT; Ferro TJ
    Am J Physiol; 1994 Sep; 267(3 Pt 1):L318-25. PubMed ID: 7943258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.